Tagashira; Junya

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tagashira; Junya.The latest application filed is for "prophylactic and/or therapeutic agent for anemia comprising tetrahydroquinoline compound as active ingredient".

Company Profile

0.11.16

Tagashira; Junya - Tokyo N/A JP
Tagashira; Junya - Higashimurayama JP
Tagashira; Junya - Higashimurayama-shi JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Phenylpyridine derivative and drug containing same Grant 9,315,493 - Miura , et al. April 19, 2	2016-04-19
Prophylactic and/or therapeutic agent for anemia comprising tetrahydroquinoline compound as active ingredient Grant 9,045,423 - Ashikawa , et al. June 2, 2	2015-06-02
Prophylactic And/or Therapeutic Agent For Anemia Comprising Tetrahydroquinoline Compound As Active Ingredient App 20140249144 - Ashikawa; Masanori ; et al.	2014-09-04
Prophylactic and/or therapeutic agent for anemia comprising tetrahydroquinoline compound as active ingredient Grant 8,791,090 - Ashikawa , et al. July 29, 2	2014-07-29
Phenylpyridine derivative and medicinal agent comprising same Grant 8,778,954 - Miura , et al. July 15, 2	2014-07-15
Compound having 3-heteroarylpyrimidin-4-(3H)-one structure and pharmaceutical preparation containing same Grant 8,664,226 - Miura , et al. March 4, 2	2014-03-04
Novel Phenylpyridine Derivative And Drug Containing Same App 20140011823 - Miura; Toru ; et al.	2014-01-09
1-acyl-4-(phenoxy, Benzyloxy, Or Phenylamino)-1,2,3,4-tetrahydroquinoline Derivatives App 20130172345 - Ashikawa; Masanori ; et al.	2013-07-04
Compound Containing A Novel 4-alkoxypyrimidine Structure And Medicine Containing Same App 20120322819 - Miura; Toru ; et al.	2012-12-20
Novel 1-(biphenyl-4-yl-methyl)-1h-imidazole Derivative And Pharmaceutical Product Containing Same App 20120264753 - Miura; Toru ; et al.	2012-10-18
Tetrahydroisoquinoline compound Grant 8,273,766 - Sato , et al. September 25, 2	2012-09-25
PAR-2 antagonists Grant 8,268,789 - Kabeya , et al. September 18, 2	2012-09-18
Novel 2-pyridone Derivative And Pharmaceutical Product Containing Same App 20120225896 - Miura; Toru ; et al.	2012-09-06
Novel Phenylpyridine Derivative And Medicinal Agent Comprising Same App 20120165353 - Miura; Toru ; et al.	2012-06-28
Novel Sulfonamide Derivative And Pharmaceutical Product Containing Same App 20120122906 - Miura; Toru ; et al.	2012-05-17
Novel Alpha-phenoxybenzeneacetic Acid Derivative And Pharmaceutical Preparation Comprising Same App 20120046308 - Miura; Toru ; et al.	2012-02-23
Novel Compound Having 3-heteroarylpyrimidin-4-(3h)-one Structure And Pharmaceutical Preparation Containing Same App 20120028983 - Miura; Toru ; et al.	2012-02-02
Prophylactic And/or Therapeutic Agent For Anemia Comprising Tetrahydroquinoline Compound As Active Ingredient App 20120004197 - Ashikawa; Masanori ; et al.	2012-01-05
Novel Compounds Comprising A 3-(5-alkoxypyrimidin-2-yl) Pyrimidin-4(3h)-one Structure And Drugs That Comprise Same App 20110306623 - Miura; Toru ; et al.	2011-12-15
Prophylactic And/or Therapeutic Agent For Anemia, Comprising Tetrahydroquinoline Compound As Active Ingredient App 20100222347 - Ashikawa; Masanori ; et al.	2010-09-02
Tetrahydroisoquinoline Compound App 20100120844 - Sato; Seiichi ; et al.	2010-05-13
Par-2 Antagonists App 20090012006 - Kabeya; Mototsugu ; et al.	2009-01-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.